Evidence map›Paper›PMID 27462135›Full record

ArticleActa histochemica et cytochemica2016

Regulation and Biological Significance of Formation of Osteoclasts and Foreign Body Giant Cells in an Extraskeletal Implantation Model.

Gazi Jased Ahmed, Eri Tatsukawa, Kota Morishita, Yasuaki Shibata, Fumio Suehiro, Masanobu Kamitakahara, Taishi Yokoi, Takehiko Koji, Masahiro Umeda, Masahiro Nishimura and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Acta histochemica et cytochemica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Modulation of αActa histochemica et cytochemica · 2019
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Gazi Jased AhmedDepartments of Clinical Oncology, Nagasaki University Graduate School of Biomedical Sciences; Department of Oral Pathology and Bone Metabolism, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.
Eri TatsukawaDepartment of Oral Pathology and Bone Metabolism, Nagasaki University Graduate School of Biomedical Sciences , 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.
Kota MorishitaDepartments of Clinical Oncology, Nagasaki University Graduate School of Biomedical Sciences; Department of Oral Pathology and Bone Metabolism, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.
Yasuaki ShibataDepartment of Oral Pathology and Bone Metabolism, Nagasaki University Graduate School of Biomedical Sciences , 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.
Fumio SuehiroDepartment of Prosthodontics, Kagoshima University Graduate School , 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.
Masanobu KamitakaharaGraduate School of Environmental Studies, Tohoku University , 6-6-20, Aramaki, Aoba-ku, Sendai, Miyagi 980-8579, Japan.
Taishi YokoiGraduate School of Environmental Studies, Tohoku University , 6-6-20, Aramaki, Aoba-ku, Sendai, Miyagi 980-8579, Japan.
Takehiko KojiDepartment of Histology and Cell Biology, Nagasaki University Graduate School of Biomedical Sciences , 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
Masahiro UmedaDepartments of Clinical Oncology, Nagasaki University Graduate School of Biomedical Sciences.
Masahiro NishimuraDepartment of Prosthodontics, Kagoshima University Graduate School , 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.
Tohru IkedaDepartment of Oral Pathology and Bone Metabolism, Nagasaki University Graduate School of Biomedical Sciences , 1-7-1 Sakamoto, Nagasaki 852-8588, Japan.
Nagasaki University · JPKagoshima University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The implantation of biomaterials induces a granulomatous reaction accompanied by foreign body giant cells (FBGCs). The characterization of multinucleated giant cells (MNGCs) around bone substitutes implanted in bone defects is more complicated because of healing with bone admixed with residual bone substitutes and their hybrid, and the appearance of two kinds of MNGCs, osteoclasts and FBGCs. Furthermore, the clinical significance of osteoclasts and FBGCs in the healing of implanted regions remains unclear. The aim of the present study was to characterize MNGCs around bone substitutes using an extraskeletal implantation model and evaluate the clinical significance of osteoclasts and FBGCs. Beta-tricalcium phosphate (β-TCP) granules were implanted into rat subcutaneous tissue with or without bone marrow mesenchymal cells (BMMCs), which include osteogenic progenitor cells. We also compared the biological significance of plasma and purified fibrin, which were used as binders for implants. Twelve weeks after implantation, osteogenesis was only detected in specimens implanted with BMMCs. The expression of two typical osteoclast markers, tartrate-resistant acid phosphatase (TRAP) and cathepsin-K (CTSK), was analyzed, and TRAP-positive and CTSK-positive osteoclasts were only detected beside bone. In contrast, most of the MNGCs in specimens without the implantation of BMMCs were FBGCs that were negative for TRAP, whereas the degradation of β-TCP was detected. In the region implanted with β-TCP granules with plasma, FBGCs tested positive for CTSK, and when β-TCP granules were implanted with purified fibrin, FBGCs tested negative for CTSK. These results showed that osteogenesis was essential to osteoclastogenesis, two kinds of FBGCs, CTSK-positive and CTSK-negative, were induced, and the expression of CTSK was plasma-dependent. In addition, the implantation of BMMCs was suggested to contribute to osteogenesis and the replacement of implanted β-TCP granules to bone.

Indexed as

beta-tricalcium phosphatecathepsin Kforeign body giant cellmacrophageosteoclast

Identifiers

PMID27462135
PMCPMC4939317
OpenAlexW2425227402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.